- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03499496
Screening for Atherotic Plaques by Ultrasound for Assessing Cardiovascular Risk
Prevalence of Atherosclerotic Carotid and/or Femoral Plaques in Patients Without Known Cardiovascular Disease and at Low-risk for Major Cardiovascular Events (AGLA/GLSA Score) Visiting a Private Primary Healthcare Practice in Switzerland
Cardiovascular disease is a common diagnosed and treated condition in private practices of primary health care. There is growing evidence that atherosclerotic plaques as predictors for stroke and heart attack are more prevalent than expected based on the clinical score in people with low risk for stroke and heart attack .
Diagnosing atherosclerotic plaques can help to decide if a lipid lowering therapy should be prescribed even if the clinical risk score is low or on the other hand if they can be observed even in high lipid levels.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Both common and proximal internal carotid arteries and both common femoral arteries (including bifurcations) were screened by ultrasound in patients who came for a check-up to a primary care practice with no known cardiovascular disease and low risk for stroke and heart attack according to the AGLA/GSLA risk score which is mostly used in Switzerland.
All patients agreed and gave written informed consent to be included in this study. Presence of plaques was defined as a focal carotid intima-media thickness >0.5 cm on ultrasound. Screening was performed by a medical doctor (DP) certified for the procedure using the following ultrasound system: Toshiba Nemio XG, probe 7.5 MhZ.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- low cardiovascular risk assessed by the AGLA/GSLA-score
Exclusion Criteria:
- cardiovascular disease
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevalence of plaques in cardiovascular low risk population
Time Frame: 1 year
|
Number of participants with the presence of carotid and/or femoral atherosclerotic plaques diagnosed via ultrasound (defined as a focal intima-media thickness >0.5 cm on ultrasound).
|
1 year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Demetrio A Pitarch, MD, Cabinet de médecine générale
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DPitarch
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atherosclerosis of Artery
-
MedtronicActive, not recruitingAtherosclerosis of Femoral Artery | Obstructive Disease | Atherosclerosis of Popliteal ArteryFrance
-
National Cerebral and Cardiovascular CenterRecruiting
-
Johns Hopkins UniversityRecruitingCoronary Artery Disease | Atherosclerosis | Coronary Atherosclerosis of Native Coronary ArteryUnited States
-
Samara State Medical UniversityRegional Samara Clinical Hospital n. a. V.D.SeredavinRecruitingCoronary Atherosclerosis of Native Coronary ArteryRussian Federation
-
Tryton Medical, Inc.CompletedCoronary Atherosclerosis of Native Coronary Artery | Bifurcation Lesions: de Novo Lesions of the Main and Side Branch of Native Coronary ArteryUnited States
-
Mayo ClinicWithdrawnSpontaneous Coronary Artery Dissection | Fibromuscular Dysplasia of Arteries | Segmental Arterial Mediolysis | Atherosclerosis of ArteryUnited States
-
Federal University of São PauloCompletedAtherosclerosis of ArteryBrazil
-
Central Hospital, Nancy, FranceSuspended
-
Zhejiang Zylox Medical Device Co., Ltd.RecruitingAtherosclerosis of Femoral ArteryGermany
-
480 BiomedicalCompletedAtherosclerosis of Femoral Artery | Superficial Femoral Artery LesionsNew Zealand, Austria, Australia, Germany
Clinical Trials on ultrasound guided detection of atherosclerotic plaques
-
Tri-Service General HospitalCompletedCarpal Tunnel SyndromeTaiwan
-
Sohag UniversityNot yet recruiting
-
Cairo UniversityAhmed Elgazzar HospitalCompleted
-
Asian Institute of Gastroenterology, IndiaUnknown
-
Northumbria Healthcare NHS Foundation TrustCompletedGreater Trochanteric Pain SyndromeUnited Kingdom
-
Universitair Ziekenhuis BrusselCompletedCancer | Malnutrition | InfectionBelgium
-
Masarykova Nemocnice v Usti nad Labem, Krajska...CompletedCentral Vein CatheterCzechia
-
University Medical Center GroningenMartini Hospital GroningenRecruitingBreast Cancer | Breast Cancer InvasiveNetherlands
-
Uniwersytecki Szpital Kliniczny w OpoluCompleted
-
Assiut UniversityNot yet recruitingPancreas Pseudocyst